Harrow, Inc. (HROW)
35.27
+0.36
(+1.03%)
USD |
NASDAQ |
Mar 17, 16:00
35.27
0.00 (0.00%)
After-Hours: 20:00
Harrow Profit Margin (Quarterly) : 7.44% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 11.83% |
| Esperion Therapeutics, Inc. | 36.71% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Theravance Biopharma, Inc. | 18.08% |
| Rhythm Pharmaceuticals, Inc. | -82.97% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.40% |
| Return on Assets | -1.38% |
| Return on Invested Capital | -1.75% |
| Gross Profit Margin (Quarterly) | 79.27% |
| Operating Margin (Quarterly) | 26.98% |
| Return on Net Operating Assets | -1.68% |